Crossmark

Combination of Ophiopogonin D, Ginsenoside Rg1, and Ginsenoside Rg3 ameliorates idiopathic pulmonary fibrosis via inhibiting type 2 alveolar epithelial cell senescence and epithelial-mesenchymal transition

Crossref DOI link: https://doi.org/10.1007/s00210-026-05384-9

Published Online: 2026-05-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Jiang

Gong, Kai

Xu, Mengzhen

Sun, Tianying

Li, Zhiyang

Liu, Yan

Li, Lingyu

Xiao, Li

Liu, Chuanguo

Zhu, Qingjun
License Information

Text and Data Mining valid from 2026-05-04

Version of Record valid from 2026-05-04
More Information

Article History

Received: 20 March 2026

Accepted: 20 April 2026

First Online: 4 May 2026

Declarations

:

: All animal experimental procedures received approval from the Animal Care and Use Committee of Shandong University of Traditional Chinese Medicine (Ethics Approval Number: SDUTCM20250909002). The ethical clearance for the animal studies was granted on September 8, 2025.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below